According to The Kobeissi Letter, UnitedHealth Group's stock, $UNH, dropped by 12% following the announcement of a civil fraud probe by the US Department of Justice into the company's Medicare billing practices. This significant price movement is critical for traders monitoring the healthcare sector, as legal challenges could further impact UnitedHealth's stock performance and market valuation.